Concepedia

Sarabjot Pabla

SP

Statistics

Publications

31

Citations

1.3K

H-Index

20

Active since

2017

Affiliations

Roswell Park Comprehensive Cancer Center(Current)

Medical College of Wisconsin

Moores Cancer Center

University of California San Diego

LabCorp (United States)

Sarabjot Pabla is an author at Roswell Park Comprehensive Cancer Center specializing in oncology, cancer immunotherapy, and immunotherapy.

Publications per year

2017–2025

31

Publications

31

Aligning tumor mutational burden (TMB) quantification across diagnostic platforms: phase II of the Friends of Cancer Research TMB Harmonization Project

Diana Merino Vega, Laura M. Yee, Lisa M. McShane et al. · Annals of Oncology · 2021 · 182 citations · Full text

Medicine, Bioinformatics, Oncology +17

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden

Carl Morrison, Sarabjot Pabla, Jeffrey M. Conroy et al. · Journal for ImmunoTherapy of Cancer · 2018 · 151 citations · Full text

Life Sciences, Dermatology, Oncology +17

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients

Sarabjot Pabla, Jeffrey M. Conroy, Mary Nesline et al. · Journal for ImmunoTherapy of Cancer · 2019 · 107 citations · Full text

Medicine, Immunology, Oncology +17

Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors

Jeffrey M. Conroy, Sarabjot Pabla, Mary Nesline et al. · Journal for ImmunoTherapy of Cancer · 2019 · 90 citations · Full text

Life Sciences, Oncology, Pathology +17

Analytical Validation of a Next-Generation Sequencing Assay to Monitor Immune Responses in Solid Tumors

Jeffrey M. Conroy, Sarabjot Pabla, Sean T. Glenn et al. · Journal of Molecular Diagnostics · 2017 · 87 citations

Medicine, Immunology, Oncology +17

1–5 of 31